SCHEMBL5268548

SCHEMBL5268548

Cc1ccc(-n2nc(C(=O)N3CCC(F)(F)CC3)cc2-c2ccc(CO)cn2)cn1

nearest known ligand 0.40

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.40
CHRNA7 P36544 2/20 0.39
GABRA1 P14867 2/20 0.39
MGLL Q99685 5/20 0.38
MALT1 Q9UDY8 1/20 0.36
HPGD P15428 1/20 0.36
HTR1A P08908 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPT P10636 1/20 0.35
WNT3A P56704 1/20 0.34
PTGS2 P35354 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5271856 0.92 CHRNA7 (0.41) KDM1ACHRNA7GABRA1MGLLMALT1
SCHEMBL5272633 0.88 CHRNA7 (0.43) KDM1ACHRNA7GABRA1MGLLMALT1
SCHEMBL4926813 0.88 VNN1 (0.39) CHRNA7MGLL
SCHEMBL5270121 0.86 CHRNA7 (0.43) KDM1ACHRNA7GABRA1MALT1HPGD
SCHEMBL5266989 0.86 KDM1A (0.51) KDM1ACHRNA7
SCHEMBL5270662 0.83 CHRNA7 (0.41) KDM1ACHRNA7GABRA1MGLLMALT1
SCHEMBL4936031 0.81 MGLL (0.38) KDM1ACHRNA7MGLLHTR1A
SCHEMBL4932048 0.80 MGLL (0.38) CHRNA7MGLLHTR1A
SCHEMBL4931012 0.80 CHRNA7 (0.39) CHRNA7MGLL
SCHEMBL4924280 0.79 MGLL (0.38) KDM1ACHRNA7MGLLHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070254881-A1 Pyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-11-01 US disclosed
US-20070254881-A1 Pyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-11-01 US disclosed
US-20070254881-A1 Pyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-11-01 US disclosed
EP-1785418-A1 PYRAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-05-16 EP disclosed
EP-1785418-A1 PYRAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-05-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254881-A1 Pyrazole Derivative PTGER1, PTGS1, PTGER2 KDM1A 1118/4885CHRNA7 4207/4885GABRA1 1499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.